Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1179-2027
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia ; day:8 ; month:9 ; year:2018 ; pages:1-11
PharmacoEconomics ; (8.9.2018), 1-11

Urheber
Bounthavong, Mark
Beteiligte Personen und Organisationen
Butler, Javed
Dolan, Chantal M.
Dunn, Jeffrey D.
Fisher, Kathryn A.
Oestreicher, Nina
Pitt, Bertram
Hauptman, Paul J.
Veenstra, David L.
SpringerLink (Online service)

DOI
10.1007/s40273-018-0709-3
URN
urn:nbn:de:101:1-2018102607385361323118
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
2025-08-15T07:20:32+0200

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Bounthavong, Mark
  • Butler, Javed
  • Dolan, Chantal M.
  • Dunn, Jeffrey D.
  • Fisher, Kathryn A.
  • Oestreicher, Nina
  • Pitt, Bertram
  • Hauptman, Paul J.
  • Veenstra, David L.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Clinical effectiveness and cost-effectiveness of ambulatory heart failure nurse-led services: an integrated review

Clinical effectiveness and cost-effectiveness of ambulatory heart failure nurse-led services: an integrated review

Strategies for cost-effectiveness analysis of rehabilitation for older patients with acute heart failure

Strategies for cost-effectiveness analysis of rehabilitation for older patients with acute heart failure

Health effectiveness and cost-effectiveness of telehealthcare for heart failure: study protocol for a randomized controlled trial

Health effectiveness and cost-effectiveness of telehealthcare for heart failure: study protocol for a randomized controlled trial

Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses

Hochschulschrift

Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses

Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes

Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes

A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction

A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction

Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review

Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review

Cost-effectiveness of the MitraClip device in German heart failure patients with secondary mitral regurgitation

Cost-effectiveness of the MitraClip device in German heart failure patients with secondary mitral regurgitation

The probability of cost-effectiveness

The probability of cost-effectiveness

Cost-effectiveness analysis for clinicians

Cost-effectiveness analysis for clinicians

Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study

Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study

Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve

Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve

Verbundene Objekte